Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Getting stranded on a long-distance train can be a maddening experience. Passengers have little recourse but to endure the delay, uncertain of its duration and knowing that appointments and ...

The AutoGuide Creators Series tells stories and amplifies creators from the car world, including family life, car buying ...

Palantir posted its ninth straight double-beat, with U.S. commercial revenue up 121% and $2.8B in bookings. Learn why PLTR ...

A record 2,846 new jobs are on the horizon for the Turks and Caicos Islands — a staggering figure that underscores the scale ...